Death N (%) | Recovery N (%) | Chi- square p-value | OR (Min, Max) | p-value | |
---|---|---|---|---|---|
Sex (N) | |||||
Men | 86 (59.3) | 54 (55.1) | 0.52 | 1 | |
Women | 59 (40.7) | 44 (44.9) | 0.94 ( 0.50, 1.78) | 0.852 | |
Age (years) | |||||
60–65 | 51 (35.2) | 19 (19.4) | 0.052 | 1 | |
66–70 | 32 (22.1) | 23 (23.4) | 0.92 (0.40, 2.10) | 0.843 | |
71–76 | 30 (20.7) | 29 (29.6) | 1.15 (0.63, 3.57) | 0.362 | |
> 76 | 32 (54.2) | 27 (27.6) | 3.19 (1.32, 7.68) | 0.01 | |
Total comorbidities (N) | |||||
0 | 13 (9.0) | 24 (24.5) | 0.021 | 1 | |
1 | 47 (32.4) | 26 (26.5) | 3.35 (1.31, 8.53) | 0.011 | |
2 | 62 (42.8) | 33 (33.7) | 3.37 (1.32, 8.65) | 0.011 | |
3 | 20 (13.8) | 14 (14.3) | 2.19 (0.72, 6.68) | 0.169 | |
4 | 3 (2.1) | 1 (1.0) | 2.02 (0.14, 29.20) | 0.605 | |
BMI | |||||
< 29.99 | 101 (69.7) | 79 (80.6) | 0.056 | 1 | |
> 30 | 44 (30.3) | 19 (19.4) | 2.39 (1.13, 5.05) | 0.023 | |
Dyspnoea (N) | |||||
No | 7 (4.8) | 4 (4.1) | 0.78 | 1 | |
Yes | 138 (95.2) | 94 (95.9) | 0.89 (0.21, 3.87) | 0.876 | |
SAP (mm Hg) | |||||
> 101 | 128 (88.3) | 88 (89.8) | 0.71 | 1 | |
< 100.9 | 17 (10.2) | 10 (10.2) | 1.33 (0.41, 4.37) | 0.635 | |
RF (breaths/min) | |||||
< 23 | 55 (37.9) | 45 (45.9) | 0.001 | 1 | |
24–28 | 54 (37.2) | 47 (48) | 0.79 (0.42, 1.47) | 0.456 | |
> 29 | 36 (24.8) | 6 (6.1) | 4.30 (1.48, 12.46) | 0.007 | |
Glucose (mg/dL) | |||||
< 199 | 92 (63.9) | 78 (79.6) | 0.009 | 1 | |
> 200.9 | 53 (36.6) | 20 (20.4) | 1.68 (0.83, 3.37) | 0.148 | |
Albumin (g/dL) | |||||
> 3.5 | 42 (29.0) | 40 (40.8) | 0.055 | 1 | |
< 3.49 | 103 (71.0) | 58 (59.2) | 1.40 (0.74, 2.67) | 0.306 | |
LDH (U/L) | |||||
< 199.9 | 14 (9.7) | 16 (16.3) | 0.12 | 1 | |
> 200 | 131 (90.3) | 82 (83.7) | 1.88 (0.79, 4.44) | 0.152 | |
sO2/FiO2 ratio | |||||
> 300 | 65 (44.8) | 69 (70.4) | 0.000 | 1 | |
< 299.9 | 80 (55.2) | 29 (29.6) | 2.32 (1.25, 4.29) | 0.008 |